SANJIVANI PARANTERAL
|
The Current P/E Ratio of SANJIVANI PARANTERAL is 27.06.
| Share Price | ₹147.2 | Jul 20,2026 |
| Market Cap | ₹181.1 Cr | |
| Earnings-TTM | ₹6.7 Cr | TTM-Consolidated Results |
| Price/Earnings | 27.06x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SANJIVANI PARANTERAL
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹181.1 Cr] as on Jul 20,2026
(/) Earnings [ ₹6.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 27.06x ]
Thus, for SANJIVANI PARANTERAL , the investors are currently willing to pay 27.06 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SANJIVANI PARANTERAL !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SANJIVANI PARANTERAL over the last five years.
Historical PE (Price/Earnings) ratio chart of SANJIVANI PARANTERAL
PE Ratio Performance Analysis for SANJIVANI PARANTERAL
- SANJIVANI PARANTERAL 's p/e ratio for fiscal years ending Mar2025 to Mar2024 averaged 31.81x.
- SANJIVANI PARANTERAL 's operated at median p/e ratio of 35.17x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, SANJIVANI PARANTERAL 's p/e ratio peaked in Mar2025 at 35.17x.
- SANJIVANI PARANTERAL 's p/e ratio hit its five-year low in Mar2024 of 28.44x.
How does SANJIVANI PARANTERAL 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SANJIVANI PARANTERAL | 6.69 | 27.06 | 181.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 40.59 | 469,382.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 75.69 | 194,375.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 89.01 | 190,308.0 |
| CIPLA LTD | 3,869.79 | 30.09 | 116,447.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 24.64 | 102,106.0 |
| MANKIND PHARMA LTD | 1,926.41 | 55.01 | 105,979.0 |
| LUPIN LTD | 5,355.47 | 21.16 | 113,317.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 22.76 | 114,379.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 25.64 | 89,790.6 |
| LAURUS LABS LTD | 889.85 | 94.66 | 84,235.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SANJIVANI PARANTERAL 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 21.16x |
| Max industry PE | 94.66x |
| Median industry PE | 30.09x |
| Average industry PE | 46.03x |
You may also like the below Video Courses